Testing effectiveness (Phase 2)Ended earlyNCT03095248
What this trial is testing
Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
Who this might be right for
Neurofibromatosis 2Vestibular SchwannomaMeningioma+2 more
Children's Hospital Medical Center, Cincinnati 10